{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T04:56:58Z","timestamp":1792299418605,"version":"4.4.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jpba.2025.117165","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T04:10:47Z","timestamp":1758946247000},"page":"117165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Quantification of the percentage of lymphocyte-binding components in polyclonal anti-thymocyte\/lymphocyte globulin products"],"prefix":"10.1016","volume":"267","author":[{"given":"Wenqu","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyong","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinyu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guizhi","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeqiong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuanhong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xilin","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jpba.2025.117165_bib1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4103\/ijmr.IJMR_752_19","article-title":"Anti-thymocyte globulin in haematology: recent developments","volume":"150","author":"Siddiqui","year":"2019","journal-title":"Indian. J. Med. Res."},{"issue":"1","key":"10.1016\/j.jpba.2025.117165_bib2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/TP.0b013e31823bb664","article-title":"Assessment of batch to batch variation in polyclonal antithymocyte globulin preparations","volume":"93","author":"Popow","year":"2012","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.jpba.2025.117165_bib3","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1097\/00007890-199504270-00020","article-title":"Comparative polyclonal antithymocyte globulin and antilymphocyte\/antilymphoblast globulin anti-CD antigen analysis by flow cytometry","volume":"59","author":"Bourdage","year":"1995","journal-title":"Transplantation"},{"issue":"12","key":"10.1016\/j.jpba.2025.117165_bib4","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1111\/ajt.12514","article-title":"A comprehensive and quantitative analysis of the major specificities in rabbit antithymocyte globulin preparations","volume":"13","author":"Popow","year":"2013","journal-title":"Am. J. Transpl."},{"key":"10.1016\/j.jpba.2025.117165_bib5","doi-asserted-by":"crossref","first-page":"7359","DOI":"10.1182\/blood-2024-203026","article-title":"Limited quality of life sacrifice for optimizing Long-Term survival: the impact of p-Alg compared to r-ATG in High-Risk hematological malignancy patients undergoing matched sibling donor transplantation","volume":"144","author":"Cheng","year":"2024","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jpba.2025.117165_bib6","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1007\/s00277-025-06335-9","article-title":"The efficacy of immunosuppressive therapy with or without thrombopoietin receptor agonist in elderly patients with severe aplastic anemia","volume":"104","author":"Li","year":"2025","journal-title":"Ann. Hematol."},{"issue":"3","key":"10.1016\/j.jpba.2025.117165_bib7","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1007\/s00277-025-06267-4","article-title":"Comparison of ATG-thymoglobulin with atg-fresenius in patients with hematological malignancies who undergo allogeneic hematopoietic stem cell transplantation: a propensity score-matched analysis","volume":"104","author":"Zhang","year":"2025","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.jpba.2025.117165_bib8","doi-asserted-by":"crossref","first-page":"1045580","DOI":"10.3389\/fimmu.2022.1045580","article-title":"ATG-Fresenius increases the risk of red blood cell transfusion after kidney transplantation","volume":"13","author":"Sebti","year":"2022","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.jpba.2025.117165_bib9","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/sj.leu.2404683","article-title":"Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond","volume":"21","author":"Mohty","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.jpba.2025.117165_bib10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3389\/fimmu.2019.00315","article-title":"Differential elimination of anti-thymocyte globulin of fresenius and genzyme impacts T-Cell reconstitution after hematopoietic stem cell transplantation","volume":"10","author":"Oostenbrink","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jpba.2025.117165_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.828094","article-title":"Therapeutic drug monitoring of Anti-Thymocyte globulin in allogeneic stem cell transplantation: proof of concept","volume":"13","author":"Meesters-Ensing","year":"2022","journal-title":"Front. Pharm."},{"issue":"2","key":"10.1016\/j.jpba.2025.117165_bib12","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.bbmt.2008.11.027","article-title":"Total and active rabbit antithymocyte globulin (rATG;Thymoglobulin\u00ae) pharmacokinetics in pediatric patients undergoing unrelated donor bone marrow transplantation","volume":"15","author":"Call","year":"2009","journal-title":"Biol. Blood Marrow Transpl."},{"issue":"4","key":"10.1016\/j.jpba.2025.117165_bib13","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.bbmt.2018.12.065","article-title":"Rabbit antithymocyte globulin serum levels: factors impacting the levels and clinical outcomes impacted by the levels","volume":"25","author":"Jamani","year":"2019","journal-title":"Biol. Blood Marrow Transpl."},{"issue":"2","key":"10.1016\/j.jpba.2025.117165_bib14","doi-asserted-by":"crossref","DOI":"10.1208\/s12248-020-0419-6","article-title":"Quantification of t cell binding polyclonal rabbit Anti-thymocyte globulin in human plasma with liquid chromatography Tandem-Mass spectrometry","volume":"22","author":"Amrani","year":"2020","journal-title":"AAPS J."},{"key":"10.1016\/j.jpba.2025.117165_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115397","article-title":"Development and application of potency assays based on genetically modified cells for biological products","volume":"230","author":"Lei","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2025.117165_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113577","article-title":"Potency assignment of biotherapeutic reference standards","volume":"191","author":"Faya","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2025.117165_bib17","article-title":"Porcine anti-human lymphocyte immunoglobulin depletes the lymphocyte population to promote successful kidney transplantation","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jpba.2025.117165_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115483","article-title":"A fully validated flow cytometry method to quantitatively analyze active rATG in human serum and its application in pharmacokinetic study for therapeutic drug monitoring","volume":"234","author":"Liu","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"6","key":"10.1016\/j.jpba.2025.117165_bib19","first-page":"320","article-title":"Establishment, validation and application of a pharmacokinetic assay for porcine anti-human t cell immunoglobulin","volume":"45","author":"Yin","year":"2022","journal-title":"Int. J. Biol."},{"issue":"1","key":"10.1016\/j.jpba.2025.117165_bib20","first-page":"761","article-title":"A comprehensive analysis of the major specificities of anti-human t lymphocyte porcine immunoglobulin (p-ATG)","volume":"104","author":"Zou","year":"2024","journal-title":"Ann. Hematol."},{"issue":"4","key":"10.1016\/j.jpba.2025.117165_bib21","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/j.1349-7006.2009.01104.x","article-title":"Efficient inhibition of SDF-1\u03b1-mediated chemotaxis and HIV-1 infection by novel CXCR4 antagonists","volume":"100","author":"Iwasaki","year":"2009","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.jpba.2025.117165_bib22","doi-asserted-by":"crossref","DOI":"10.1186\/s12864-018-4718-6","article-title":"A genome-wide survey of mutations in the jurkat cell line","volume":"19","author":"Gioia","year":"2018","journal-title":"BMC Genom."},{"issue":"5","key":"10.1016\/j.jpba.2025.117165_bib23","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/s41375-021-01231-3","article-title":"Somatic mutations in lymphocytes in patients with immune-mediated aplastic anemia","volume":"35","author":"Lundgren","year":"2021","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.jpba.2025.117165_bib24","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1159\/000323769","article-title":"A comparison of jurkat Cell-Reactive Anti-T lymphocyte globulin and fetal Anti-Thymocyte globulin preparations in the treatment of aplastic anemia","volume":"20","author":"Serefhanoglu","year":"2011","journal-title":"Med. Princ. Pr."},{"key":"10.1016\/j.jpba.2025.117165_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1017850","article-title":"Lower dose of ATG combined with basiliximab for haploidentical hematopoietic stem cell transplantation is associated with effective control of GVHD and less CMV viremia","volume":"13","author":"Huang","year":"2022","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.jpba.2025.117165_bib26","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000446835","article-title":"Impact of ATG dose on the outcome of patients undergoing reduced intensity conditioning followed by allogeneic hematopoietic stem cell transplantation for hematological malignancies","volume":"136","author":"Cornillon","year":"2016","journal-title":"Acta Haematol."},{"issue":"1","key":"10.1016\/j.jpba.2025.117165_bib27","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/bjh.19205","article-title":"Effectiveness of in vivo T-cell-depleted regimen containing porcine anti-lymphocyte globulin or rabbit anti-thymocyte globulin in preventing acute graft-versus-host disease after haploidentical haematopoietic stem cell transplantation","volume":"204","author":"Xu","year":"2024","journal-title":"Br. J. Haematol."},{"issue":"6","key":"10.1016\/j.jpba.2025.117165_bib28","first-page":"331","article-title":"Optimal active Anti-Thymocyte globulin exposure associated with minimum risk of virus reactivation and comparable acute Graft-Versus-Host disease under adult myeloablative haploidentical peripheral blood stem cell transplantation","volume":"28","author":"Wang","year":"2022","journal-title":"Transpl. Cell. Ther."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525005060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525005060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T15:25:42Z","timestamp":1762269942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708525005060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":28,"alternative-id":["S0731708525005060"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2025.117165","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantification of the percentage of lymphocyte-binding components in polyclonal anti-thymocyte\/lymphocyte globulin products","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2025.117165","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117165"}}